Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new study, investigators examined three parallel, prospective, ongoing, cumulative registry studies of over 1,000 men. Their analysis showed that long-term T therapy in hypogonadal men is safe and does not increase the risk of PCa.

Lead investigator Ahmad Haider, MD, PhD, urologist, Bremerhaven, Germany, states, ‘Although considerable evidence exists indicating no relationship between testosterone and increased risk of developing PCa, decades of physician training with the notion that testosterone is fuel for PCa made it difficult to dispel such fallacy and the myth continued to persist. Nevertheless, in the absence of long-term follow-up data demonstrating reduced risk of PCa in hypogonadal men who are receiving T therapy, considerable skepticism remains throughout the medical community and this is an expected natural and acceptable path of medical and scientific discourse. In view of the current evidence, clinicians are compelled to think this over and cannot justify withholding T therapy in hypogonadal men, also in men who have been successfully treated for PCa.’ EurekAlert

The Critical Care Recovery Center care model — the USA

Survey of Swedish anesthesia personnel reveals the need to improve knowledge, particularly in elderly and fragile patients.
Postsurgical cognitive side effects can have major implications for the level of care, length of hospital stay, and the patient

Patients who use a continuous positive airway pressure (CPAP) device to treat obstructive sleep apnea (OSA) often believe that it makes them less sexually attractive, according to researchers at Rosalind Franklin University. A new study abstract released shows that they do not need to worry.
Erectile dysfunction (ED) is common in sleep apnea patients, but studies have shown that the use of CPAP improves ED. However, patients using CPAP may believe that the use of CPAP will have a negative influence on sexual quality, which can in turn make them less likely to use CPAP. Researchers conducted a survey to determine if sexual quality of life (SQOL) differs between CPAP-compliant and noncompliant patients. Patients were deemed to be compliant if they used CPAP more than 4 hours per night for 70% of days.
In this study, 52 patients with OSA on CPAP answered 10 questions pertaining to physical and emotional aspects of lovemaking. Of the 52 patients, 27 were compliant with CPAP, 25 were not. Both groups were similar in age, body mass index, ED, use of medication to treat erectile dysfunction, and presence of depression. Results showed that, when adjusting for all confounding variables, CPAP compliance does not predict sexual quality of life.

Emergency physicians can safely reduce x-rays in children with hurt ankles by as much as 23 percent and save emergency patients both money and time.  The results of a cost analysis of the Low Risk Ankle Rule (LRAR) were published online Tuesday .